Oramed Pharmaceuticals Inc (ORMP)

Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	100.00%-	1.59	1.99	-	-
Research and Development	100.00%-	1.59	1.99	-	-
Operating Income/Loss	24.41%-2.77	-3.66	-5.67	-2.43	-2.49
Nonoperating Income/Loss	131.32%103.74	44.85	15.18	61.47	15.37
Income/Loss From Continuing Operations Before Tax	105.48%101.59	49.44	9.80	59.45	13.13
Income Tax Expense/Benefit, Current	26.28%1.63	1.29	-	-	-
Income Tax Expense/Benefit, Deferred	21.80	-	-	-	-
Income Tax Expense/Benefit	110.52%23.43	11.13	-0.21	11.06	-0.13
	104.01%78.16	38.31	10.01	48.39	13.26
Attributable To Parent	104.01%78.16	38.31	10.01	48.40	13.29
Available To Common Stockholders, Basic	104.01%78.16	38.31	-	48.40	13.29
Basic Average Shares	0.65%41.04	40.77	-	41.76	41.74
Diluted Average Shares	1.27%42.50	41.97	-	42.77	42.61
Basic Earnings Per Share	102.13%1.90	0.94	-	1.16	0.32
Diluted Earnings Per Share	102.20%1.84	0.91	-	1.13	0.31